Ananya Panda1, Yong Chen2, Satyam Ghodasara3, Katherine Wright1, Nicole Seiberlich4,5, Mark Alan Griswold1,4,5, and Vikas Gulani1,4,5
1Radiology, Case Western Reserve University, Cleveland, OH, United States, 2Radiology, University of North Carolina, Chapel Hill, NC, United States, 3Case Western School of Medicine, Cleveland, OH, United States, 4Radiology, University Hospitals Cleveland Medical Center, Cleveland, OH, United States, 5Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States
Synopsis
3D
Breast Magnetic Resonance Fingerprinting (MRF) allows simultaneous breast
tissue T1 and T2 mapping. In this study, same session repeatability
of 3D MRF technique in normal breast tissue was evaluated (test/retest 10
minutes apart) and in two consecutive visits. The within subject coefficient of
variance (wCV) for two visit scans was < 6% for T1 and < 5% for
T2. The wCV for test-retest scan for T1 was <5% and
for T2 was 6.5%. One-week repeatability of 3D MRF was good for both
T1 and T2 (ICC T1: 0.81 T2: 0.88 at second visit). These
variations are smaller than observed inter-subject variability. Thus breast MRF
may be useful for longitudinal patient follow-up.
Target Audience
Basic
and clinical scientists interested in quantitative imaging and breast MRI.Introduction
3D-Magnetic
Resonance Fingerprinting (MRF) is a recently developed technique which provides
volumetric breast coverage and allows simultaneous mapping of T1 and T2
relaxation times of breast tissue in a clinically feasible scan1.
The T1 and T2 relaxation times for normal breast tissue
obtained from 3D MRF have been comparable to literature values at 3T2.
Clinically, measurements obtained from 3D MRF may be useful in lesion
characterization or assessment of treatment response. However, in order to
interpret the T1 and T2 in tumors and change after treatment,
it is important to understand the repeatability of this technique in normal
breast tissue. The purpose of this work is to evaluate 3D breast MRF
test-retest repeatability in the same visit and across two different visits in
normal breast tissue.Methods
In
this IRB approved study, 12 healthy pre-menopausal volunteers were scanned with
3D MRF twice within 7-15 days. In addition, 5 volunteers also consented to a test-retest
scan in the same sitting, in which 3D MRF was done before and after
repositioning with a 10 minute scan interval. All scans were performed on a 3T
scanner (Verio, Siemens) using an 8-channel breast coil. The 3D MRF sequence
was based on a FISP acquisition with a fat-saturation module1. Other
imaging parameters included: FOV=40×40 cm; matrix size 256×256; slice thickness
3 mm; number of partitions, 48; partial Fourier in the partition direction,
6/8. The overall acquisition time for 48 partitions was 5.5 minutes. The 3D MRF
partition with the largest area of normal breast tissue in that partition was
selected. Region of Interests (ROIs) were manually drawn by one radiologist (7
years radiology experience). Separate ROIs were drawn for right and left breast
(Figure 1). For retest and repeatability analysis, ROIs were drawn on the partition
showing anatomy of breast tissue as the reference scan. The mean T1
and T2 values from all voxels within each ROI were obtained. For
both test-retest (n = 5) and two-visit (n = 12) repeatability, the between-subject
coefficient of variance (bCV), and within-subject coefficient of variance (wCV)
were computed for both breasts. Intraclass correlation coefficient (ICC) and
coefficient of repeatability (CR) were also estimated for both breasts. Results
The
mean age was 28 years, median age 29 years, range 22-33 years. Table 1 summarizes
all results for two-visit as well as test-retest repeatability analysis. Figure
2 shows relationship of T1 and T2 values between visit 1
and visit 2. Figure 3 shows Bland-Altman plots for two-visit repeatability for
all ROIs in both breasts. While bCV was in the range of 10-15% (Table 1), the
wCV was 5.5-5.7% for T1 and 4.3-4.8% for T2. Agreement
was good-to-excellent for both T1 and T2 (ICC > 0.75). Figure 3 shows test-retest
relationship for T1 and T2 for both breasts. Again the
bCV was higher but the wCV was within 3-7% for T1 and T2 (Table
1).Discussion
This
work shows the repeatability of 3D MRF measurements in a single-institution
setting. The wCV for breast MRF is comparable or smaller than wCV of ADC
(5-11%) reported previously3,4,5. The higher bCV indicates a larger
inter-subject variation either due to difference in breast tissue composition
or scanning in different phases of hormonal cycles across different subjects..
While repeat scans were not confined to a particular phase of menstrual cycle, the
high ICC and low wCV suggests that the values are repeatable across different
cycles, though further work is needed. Thus 3D MRF may be useful in
longitudinal follow-up of individual subjects and affect size greater than 7%
ought to be measurable in longitudinal follow-ups.Conclusion
3D
MRF measurements in normal breast tissue are repeatable across various scan
timings and may be useful in clinical applications in breast imaging.Acknowledgements
Research Support: NIH grants 1R01DK098503, 1R00EB016728 and Siemens HealthineersReferences
1. Chen Y, et
al. 3D Magnetic Resonance Fingerprinting for Quantitative Breast Imaging,,
Abstract 0399, 24th ISMRM, 2016. 2. Rakow-Penner R, et al. Relaxation times of
breast tissue at 1.5T and 3T measured using IDEAL. JMRI. 2006;23:87-91. 3. Aliu
S, et al. Repeatability of Quantitative MRI Measurements in Normal Breast
Tissue. Trans Oncol. 2014:7:130-137. 4. O’Flynn EAM, et al. Diffusion weighted
imaging of the normal breast: reproducibility of apparent diffusion coefficient
measurements and variation with menstrual cycle and menopausal status. Eur
Radiol. 2012. 22; 1512-1518.
5 Newitt DC, et al. Reproducibility of ADC measurements by Breast DWI: Results
of the ACRIN 6698 Trial. Abstract 0949, 25th ISMRM 2017.